Literature DB >> 2893373

An extended HLA-D region haplotype associated with celiac disease.

M D Howell1, J R Smith, R K Austin, D Kelleher, G T Nepom, B Volk, M F Kagnoff.   

Abstract

Celiac disease has one of the strongest associations with HLA (human leukocyte antigen) class II markers of the known HLA-linked diseases. This association is primarily with the class II serologic specificities HLA-DR3 and -DQw2. We previously described a restriction fragment length polymorphism (RFLP) characterized by the presence of a 4.0-kilobase Rsa I fragment derived from an HLA class II beta-chain gene, which distinguishes the class II HLA haplotype of celiac disease patients from those of many serologically matched controls. We now report the isolation of this beta-chain gene from a bacteriophage genomic library constructed from the DNA of a celiac disease patient. Based on restriction mapping and differential hybridization with class II cDNA and oligonucleotide probes, this gene was identified as one encoding an HLA-DP beta chain. This celiac disease-associated HLA-DP beta-chain gene was flanked by HLA-DP alpha-chain genes and, therefore, was probably in its normal chromosomal location. The HLA-DP alpha-chain genes of celiac disease patients also were studied by RFLP analysis; 84% of HLA-DR3, -DQw2 patients had a 16-kb Xba I fragment that was present in only 36% of HLA-DR3, -DQw2 controls. Moreover, 79% of these patients had both alpha- and beta-chain polymorphisms in contrast to 27% of controls. Thus, celiac disease is associated with a subset of HLA-DR3, -DQw2 haplotypes characterized by HLA-DP alpha- and beta-chain gene RFLPs. Within the celiac-disease patient population, the joint segregation of these HLA-DP genes with those encoding the serologic specificities HLA-DR3 and -DQw2 indicates: (i) that the class II HLA haplotype associated with celiac disease is extended throughout the entire HLA-D region, and (ii) that celiac-disease susceptibility genes may reside as far centromeric on this haplotype as the HLA-DP subregion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893373      PMCID: PMC279516          DOI: 10.1073/pnas.85.1.222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  The molecular basis of autoimmunity.

Authors:  H O McDevitt
Journal:  Clin Res       Date:  1986-04

2.  Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis.

Authors:  D A Hardy; J I Bell; E O Long; T Lindsten; H O McDevitt
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy.

Authors:  C A Alper; E Fleischnick; Z Awdeh; A J Katz; E J Yunis
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Polymorphic restriction endonuclease sites linked to the HLA-DR alpha gene: localization and use as genetic markers of insulin-dependent diabetes.

Authors:  D Stetler; F C Grumet; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals.

Authors:  D Owerbach; A Lernmark; P Platz; L P Ryder; L Rask; P A Peterson; J Ludvigsson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

7.  HLA-DQ beta-chain polymorphism linked to myasthenia gravis.

Authors:  J Bell; L Rassenti; S Smoot; K Smith; C Newby; R Hohlfeld; K Toyka; H McDevitt; L Steinman
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

8.  Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis.

Authors:  G T Nepom; C E Seyfried; S L Holbeck; K R Wilske; B S Nepom
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

9.  Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis.

Authors:  B S Nepom; J Palmer; S J Kim; J A Hansen; S L Holbeck; G T Nepom
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  An HLA-D region restriction fragment length polymorphism associated with celiac disease.

Authors:  M D Howell; R K Austin; D Kelleher; G T Nepom; M F Kagnoff
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Understanding the molecular basis of coeliac disease.

Authors:  M F Kagnoff
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 2.  Molecular biology and coeliac disease.

Authors:  P D Howdle; G E Blair
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

3.  Molecular analysis of HLA-DQ A alleles in coeliac disease lack of a unique disease-associated sequence.

Authors:  V Mantovani; G R Corazza; G Angelini; L Delfino; M Frisoni; P Mirri; R A Valentini; P Barboni; G Gasbarrini; G B Ferrara
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  HLA-DP and coeliac disease: family and population studies.

Authors:  C Caffrey; G A Hitman; M J Niven; P G Cassell; P Kumar; L Fry; P Mackintosh; R Gallagher; C Feighery; D Weir
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

5.  A locus telomeric to HLA-DPB encodes susceptibility to coeliac disease.

Authors:  W M Rosenberg; B P Wordsworth; D P Jewell; J I Bell
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Structural analysis of the HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17) haplotype.

Authors:  M F Kagnoff; J I Harwood; T L Bugawan; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Analysis of RNA transcripts for HLA class II genes in human small intestinal biopsies.

Authors:  B A Volk; D A Brenner; M F Kagnoff
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

8.  Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes.

Authors:  T L Bugawan; A B Begovich; H A Erlich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Studies on the interaction between alpha-gliadin and HLA and T cell receptor molecules in coeliac disease.

Authors:  R B Gallagher; C Feighery; D G Weir; C P Kelly; C A Whelan
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis.

Authors:  A B Begovich; T L Bugawan; B S Nepom; W Klitz; G T Nepom; H A Erlich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.